NDC 0002-4117-01 - Zyprexa

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0002-4117
Requested NDC: 0002-4117-01
Package NDCs from labels: 0002-4117-30, 0002-4117-01
Manufacturer: Eli Lilly and Company
Effective date: 2025-11-18
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Zyprexa - Eli Lilly and Company	Eli Lilly and Company	2025-11-18	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Dispensing Solutions, Inc.	Dispensing Solutions, Inc.	2011-10-04	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Rebel Distributors Corp	Rebel Distributors Corp	2010-12-01	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2009-11-30	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2012-07-24	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0002-4117-30	Zyprexa	30 in 1 BOTTLE	TABLET	30		67

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-4117	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	66	Legacy NDC, 1 package rows	20250110_d5051fbc-846b-4946-82df-341fb1216341.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-4117-01	EA - Each	0002-4117	57dd532e-74e8-4256-8cd2-6412fa66a638	1	2012-07-24
0002-4117-04	EA - Each	0002-4117	a3475d2f-1578-46db-af34-be7f5923d746	1	2012-07-24
0002-4117-30	EA - Each	0002-4117	231839e9-8446-4930-a183-ce53c2a5f658	1	2012-07-24
0002-4117-33	EA - Each	0002-4117	700f2e27-7228-47d4-810d-39eb23f92933	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Aspartame	INACTIVE INGREDIENT	Z0H242BBR1	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Ferric Oxide Red	INACTIVE INGREDIENT	1K09F3G675	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Gelatin	INACTIVE INGREDIENT	2G86QN327L	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Mannitol	INACTIVE INGREDIENT	3OWL53L36A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Methylparaben Sodium	INACTIVE INGREDIENT	CR6K9C2NHK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Polyethylene glycol 4000	INACTIVE INGREDIENT	4R4HFI6D95	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Propylparaben Sodium	INACTIVE INGREDIENT	625NNB0G9N	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Tartaric acid	INACTIVE INGREDIENT	W4888I119H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
Ferric Oxide Red	INACTIVE INGREDIENT	1K09F3G675	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
Hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Polyethylene glycol 4000	INACTIVE INGREDIENT	4R4HFI6D95	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [REBEL DISTRIBUTORS CORP]	1
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 89 of 113 · 2,241 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Proceuticals Private Label by TiZO tinted foaming mineral sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Fallien Cosmeceuticals, Ltd	1e78109f-4d2e-2705-e063-6294a90a5ad3	2024-07-30	Warnings	Exact identifier unii: 15FIX9V2JP
Replenix Sheer SPF 50	ZINC OXIDE TITANIUM DIOXIDE	Topiderm, Inc.	37d1f454-3bc9-4ce5-863c-0d4f6fa18fb4	2024-07-29	Warnings	Exact identifier unii: 15FIX9V2JP
Derma E Sun Defense Face SPF 30	ZINC OXIDE TITANIUM DIOXIDE	derma e	d90b8f81-de7a-4022-800a-90f063e94180	2024-07-17	Warnings	Exact identifier unii: 15FIX9V2JP
PROCEUTICALS PRIVATE LABEL by TiZO mineral lip sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Fallien Cosmeceuticals, LTD	1d611494-648b-6e5f-e063-6294a90a4500	2024-07-16	Warnings	Exact identifier unii: 15FIX9V2JP
SkinCeuticals Physical Fusion UV Defense Broad Spectrum SPF 50 Sunscreen	TITANIUM DIOXIDE AND ZINC OXIDE	L'Oreal USA Products Inc	8df98d97-a5d2-4d52-8bd2-130a13501d60	2024-07-16	Warnings	Exact identifier unii: 15FIX9V2JP
Derma E Sun Defense SPF 30	ZINC OXIDE AND TITANIUM DIOXIDE	derma e	395b73a4-dae7-49da-9dab-ab622117c8c0	2024-07-12	Warnings	Exact identifier unii: 15FIX9V2JP
PROCEUTICALS PRIVATE LABEL by TiZO non-tinted mineral sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Fallien Cosmeceuticals, LTD	1ce8c1da-565d-5487-e063-6294a90a1bde	2024-07-10	Warnings	Exact identifier unii: 15FIX9V2JP
PROCEUTICALS PRIVATE LABEL by TiZO daily defense tinted mineral sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Fallien Cosmeceuticals, LTD	1cc19337-cf54-af5d-e063-6394a90a1ceb	2024-07-08	Warnings	Exact identifier unii: 15FIX9V2JP
Olanzapine	OLANZAPINE	NorthStar RxLLC	ea3259d5-36ee-4ac9-b849-9625626e2187	2024-07-03	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 200034 rxcui: 283639 rxcui: 312079 rxcui: 312077 rxcui: 314154 rxcui: 312078 unii: N7U69T4SZR
Exel Clarifying Line SPF 50	OCTINOXATE, OCTOCRYLENE, OXYBENZONE, TATANIUM DIOXIDE	Exelencia importers	0d6d4098-4121-477e-b404-3ab18628ed68	2024-06-30	Warnings	Exact identifier unii: 15FIX9V2JP
Maybelline New York Dream Fresh BB Beauty Balm Skin Perfector Broad Spectrum SPF 30 Sunscreen	TITANIUM DIOXIDE	L'Oreal USA Products Inc	28c51c59-dbfb-45e5-b536-6e5d5c5560d6	2024-06-28	Warnings	Exact identifier unii: 15FIX9V2JP
Olanzapine	OLANZAPINE	Qilu Pharmaceutical Co., Ltd.	6077f5c4-01d7-4c1d-97a0-cb859f98ce68	2024-06-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 200034 rxcui: 283639 rxcui: 312079 rxcui: 312077 rxcui: 314154 rxcui: 312078 unii: N7U69T4SZR
LOreal Paris Infallible UP TO 32H Fresh Wear Foundation Broad Spectrum SPF 25 Sunscreen	OCTINOXATE AND TITANIUM DIOXIDE	L'Oreal USA Products Inc	f6457973-3718-44cd-a764-de0b089d4eee	2024-06-28	Warnings	Exact identifier unii: 15FIX9V2JP
LOreal Paris Visible Lift Serum Absolute Advanced Makeup Broad Spectrum SPF 17 Sunscreen	OCTINOXATE AND TITANIUM DIOXIDE	L'Oreal USA Products Inc	8598d56b-adcd-48e8-b6fc-77bc934009c7	2024-06-27	Warnings	Exact identifier unii: 15FIX9V2JP
Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen	OCTINOXATE AND TITANIUM DIOXIDE	L'Oreal USA Products Inc	be2a83fb-e4f8-4313-b5bd-150f351fb345	2024-06-26	Warnings	Exact identifier unii: 15FIX9V2JP
Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen	OCTINOXATE AND TITANIUM DIOXIDE	SICOS ET CIE	066a0951-2e7e-40c0-8035-4d708a32f16c	2024-06-26	Warnings	Exact identifier unii: 15FIX9V2JP
Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 30 Sunscreen Luminous Matte Foundation	OCTINOXATE AND TITANIUM DIOXIDE	SICOS ET CIE	66a91768-6012-485a-b569-a293ea6d4880	2024-06-24	Warnings	Exact identifier unii: 15FIX9V2JP
Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 30 Sunscreen Luminous Matte Foundation	OCTINOXATE AND TITANIUM DIOXIDE	L'Oreal USA Products Inc	43539766-2e70-4b42-b64b-1d30367b2eb9	2024-06-24	Warnings	Exact identifier unii: 15FIX9V2JP
Exel Clarifying Line SPF 50	OCTINOXATE, OCTOCRYLENE, OXYBENZONE, TATANIUM DIOXIDE	Biocosmetica Exel Argentina SRL	e65a68f6-d1b7-4cbf-a3f8-5cc04036221a	2024-06-23	Warnings	Exact identifier unii: 15FIX9V2JP
Protectif Fair Tint	ZINC OXIDE AND TITANIUM DIOXIDE	Derma Research Group Inc.	1a8c8804-1d6b-b5a5-e063-6394a90a1260	2024-06-18	Warnings	Exact identifier unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.